SAREPTA THERAPEUTICS, INC. Contractual Obligation, to be Paid, after Year Five
SAREPTA THERAPEUTICS, INC. (SRPT) had Contractual Obligation, to be Paid, after Year Five of $0 as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueAfterFifthYear · last filed 2024-02-28
- 2023-12-31: Contractual Obligation, to be Paid, after Year Five $0.00.
- 2022-12-31: Contractual Obligation, to be Paid, after Year Five $117.22M.
- 2021-12-31: Contractual Obligation, to be Paid, after Year Five $109.44M.
- 2020-12-31: Contractual Obligation, to be Paid, after Year Five $138.22M.
| Period end | Contractual Obligation, to be Paid, after Year Five |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2022-12-31 | $117.22M 10-K · filed 2023-02-28 |
| 2021-12-31 | $109.44M 10-K · filed 2022-03-01 |
| 2020-12-31 | $138.22M 10-K · filed 2021-03-01 |
| 2019-12-31 | $149.35M 10-K · filed 2020-02-26 |
| 2018-12-31 | $124.00M 10-K · filed 2019-02-28 |
| 2018-09-30 | $160.00M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $160.00M 10-Q · filed 2018-08-08 |
| 2014-09-30 | $5.71M 10-Q · filed 2014-11-06 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |